Second-generation Modular Acetabular Components Provide Fixation at 10 to 16 Years

Chapel Hill Orthopedics Surgery and Sports Medicine, 101 Conner Drive, Suite 200, Chapel Hill, NC 27514, USA.
Clinical Orthopaedics and Related Research (Impact Factor: 2.77). 06/2011; 470(2):366-72. DOI: 10.1007/s11999-011-1950-7
Source: PubMed


First-generation modular titanium fiber-metal-coated acetabular components had high rates of wear, pelvic osteolysis, and liner dissociation. Second-generation components were designed to reduce the incidence of these problems but it is unclear whether the changes achieved these goals.
We asked the following questions: (1) Is the risk of revision surgery for loosening, wear, or liner dissociation low with the second-generation acetabular component? (2) Is the rate of pelvic osteolysis low? (3) Can the liner be exchanged without bone cement?
We retrospectively reviewed prospectively collected data from 99 patients (118 hips) undergoing THAs with one second-generation modular titanium acetabular component with routine screw fixation and conventional polyethylene. The minimum followup was 10 years (mean, 12 years; range, 10-16 years). We obtained Harris hip scores and examined radiographs for loosening and osteolysis.
At last followup, all acetabular components were well fixed and no titanium shell had been revised or removed. No liner had dissociation. At most recent followup, the mean Harris hip score was 89. We observed pelvic osteolysis in eight hips (7%). There were three reoperations for dislocation (head-liner exchange only) and three loose femoral components revised. Two liners (at 11 and 14 years) were exchanged for wear-pelvic osteolysis.
This second-generation modular titanium fiber-metal-coated acetabular component with screw fixation had no loosening, no liner dissociation, and a low rate of pelvic osteolysis at 10 to 16 years. Liner exchange is practical without use of cement. We continue to use this component with highly crosslinked polyethylene liners.
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Managing blood loss in total hip arthroplasty (THA) minimizes complications and decreases cost. Tissue-sparing anterior supine intermuscular THA (ASI-THA) may offer a quicker recovery but increases blood loss and transfusion requirements. This double-blinded prospective study compared a bipolar sealer (Aquamantys 6.0 bipolar sealer) to standard monopolar electrocautery in reducing blood loss in ASI-THA. Differences in calculated actual blood loss (ABL), hemoglobin, and transfusion requirements were examined. One hundred hips were randomized to each group. Transfusion rates were similar, 6% and 4%, respectively (p>0.05). ABL and change in hemoglobin were identical (1.35 and 3.3g). No significant differences in transfusion, blood loss, or hemoglobin were seen with a bipolar sealer device. Routine use of this bipolar sealer device has been discontinued in ASI-THA.
    No preview · Article · Mar 2013 · The Journal of arthroplasty
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acetabular revision of a total hip arthroplasty using jumbo components (Mayo definition, ≥62 mm in women and ≥66 mm in men) offers distinct advantages in patients with notable acetabular bone loss. However, there are little data on the long-term survival and complications associated with use of these components. This retrospective study of prospectively collected data included 120 patients who underwent 129 revision total hip arthroplasties with jumbo cups. Data on infection, aseptic loosening, reoperation, and dislocation were analyzed. One hundred and one patients (108 hips) with a mean follow-up of 8.1 years (range, two to twenty years) were evaluated with use of the Harris hip score and radiographic evidence of loosening, radiolucent lines, and osteolysis. Kaplan-Meier survivorship was calculated at ten and fifteen years with use of three different end points. Demographic and operative factors associated with implant survival and dislocation were analyzed with use of chi-square and Wilcoxon tests. Four (3.1%) of the jumbo components were removed for infection and four hips (3.1%) had aseptic implant loosening. Reoperation for any reason was performed in twenty hips. With failure defined as cup revision for aseptic loosening or radiographic evidence of loosening, implant survival was 97.3% (95% confidence interval [CI], 89.6% to 99.3%) at ten years and 82.8% (95% CI, 59% to 97.6%) at fifteen years. With failure defined as cup removal for any reason, implant survival was 93.8% (95% CI, 83.4% to 97.2%) at ten years and 79.8% (95% CI, 61.1% to 95.4%) at fifteen years. There was no significant association between Paprosky type, component coating, or patient characteristics and failure. Dislocation occurred in twelve (9.3%) of the hips (10% of the patients) and three underwent reoperation. A femoral head size of ≥32 mm was associated with a significantly lower risk of dislocation compared with smaller sizes. Jumbo acetabular components with screw fixation were associated with low rates of infection and loosening after revision total hip arthroplasty and had high survival at fifteen years. Reoperation for wear and loosening increased in the second decade. Dislocation was the most common complication and was significantly associated with smaller femoral head sizes. Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
    No preview · Article · Mar 2013 · The Journal of Bone and Joint Surgery
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: The purpose of this study was to evaluate the long-term clinical and radiographic outcomes of the Balgrist total hip replacement cup. Methods: We report the results of a retrospective review of 195 total hip prostheses with Balgrist cup implanted in 178 patients. There were 59 men and 119 women with a mean age at surgery of 52.3 years (range, 19-72). Cox regression was used to determine the influence of independent variables on the survivorship of the prosthesis. Results: There were 117 (66 %) of 178 patients, and 131 (67 %) of 195 hips available for assessment at a mean follow-up of 17.4 years. A total of 21 patients (22 hips) were lost from follow-up (12 %). A total of 25 patients (27 hips) required some type of re-operation during the follow-up period. Eight of 27 re-operations (30 %) were directly caused by the Balgrist cup failure due to fatigue fracture of the metallic shell (n = 5; 19 %), polyethylene wear (n = 2; 7 %) and aseptic loosening (n = 1; 4 %). The mean polyethylene wear rate was 0.068 mm/year (range, 0.008-0.230; SD = 0.043). The risk of re-operation for any reason was decreased with dysplastic hip as a primary diagnosis (hazard ratio; HR = 0.250; 95 % CI 0.086-0.725) and with greater age at the time of surgery (HR = 0.923; 95 % CI 0.880-0.969). The 19-year survivorship with re-operation for any reason was 75.6 % (95 % CI 67.0-84.2). The 19-year survivorship with re-operation for the Balgrist cup failure was 90.5 % (95 % CI 83.4-97.6). Conclusions: The Balgrist cup continues to provide excellent clinical and radiological outcomes. This is associated at least in part with a low polyethylene wear rate. The main reason for the Balgrist cup failure is fatigue fracture of the metallic shell.
    No preview · Article · Jun 2013 · International Orthopaedics
Show more